Interactions of a novel inhibitor from an extremophilic Bacillus sp with HIV-1 protease -: Implications for the mechanism of inactivation

被引:18
作者
Dash, C [1 ]
Rao, M [1 ]
机构
[1] Natl Chem Lab, Div Biochem Sci, Pune 411008, Maharashtra, India
关键词
D O I
10.1074/jbc.M005662200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The active site cleft of the HIV-1 protease (PR) is bound by two identical conformationally mobile loops known as flaps, which are important for substrate binding and catalysis, The present article reports, for the first time, an HIV-1 PR inhibitor, ATBI, from an extremophilic Bacillus sp. The inhibitor is found to be a hydrophilic peptide with Mr of 1147, and an amino acid sequence of Ala-Gly-Lys-Lys-Asp-Asp-Asp-Asp-Pro-Pro-Glu, Sequence homology exhibited no similarity with the reported peptidic inhibitors of HIV-1 PR. Investigation of the kinetics of the enzyme-inhibitor interactions revealed that ATBI is a noncompetitive and tight binding inhibitor with the IC50 and K-i values 18.0 and 17.8 nM, respectively. The binding of the inhibitor with the enzyme and the subsequent induction of the localized conformational changes in the flap region of the HIV-1 PR were monitored by exploiting the intrinsic fluorescence of the surface exposed Trp-42 residues, which are present at the proximity of the flaps. We have demonstrated by fluorescence and circular dichroism studies that ATBI binds in the active site of the HIV-1 PR and thereby leads to the inactivation of the enzyme. Based on our results, we propose that the inactivation is due to the reorganization of the flaps impairing its flexibility leading toward inaccessibility of the substrate to the active site of the enzyme.
引用
收藏
页码:2487 / 2493
页数:7
相关论文
共 43 条
  • [1] EVALUATION OF SECONDARY STRUCTURE OF PROTEINS FROM UV CIRCULAR-DICHROISM SPECTRA USING AN UNSUPERVISED LEARNING NEURAL-NETWORK
    ANDRADE, MA
    CHACON, P
    MERELO, JJ
    MORAN, F
    [J]. PROTEIN ENGINEERING, 1993, 6 (04): : 383 - 390
  • [2] AN INHIBITOR OF THE PROTEASE BLOCKS MATURATION OF HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES AND SPREAD OF INFECTION
    ASHORN, P
    MCQUADE, TJ
    THAISRIVONGS, S
    TOMASSELLI, AG
    TARPLEY, WG
    MOSS, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) : 7472 - 7476
  • [3] Structure-based thermodynamic analysis of HIV-1 protease inhibitors
    Bardi, JS
    Luque, I
    Freire, E
    [J]. BIOCHEMISTRY, 1997, 36 (22) : 6588 - 6596
  • [4] *BIOS MOL SIM, 1995, INS 2
  • [5] RETROVIRAL PROTEINASES - A 2ND FRONT AGAINST AIDS
    BLUNDELL, T
    PEARL, L
    [J]. NATURE, 1989, 337 (6208) : 596 - 597
  • [6] TIGHT-BINDING INHIBITORS .3. NEW APPROACH FOR DETERMINATION OF COMPETITION BETWEEN TIGHT-BINDING INHIBITORS AND SUBSTRATES-INHIBITION OF ADENOSINE-DEAMINASE BY COFORMYCIN
    CHA, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 1976, 25 (24) : 2695 - 2702
  • [7] HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS
    DARKE, PL
    NUTT, RF
    BRADY, SF
    GARSKY, VM
    CICCARONE, TM
    LEU, CT
    LUMMA, PK
    FREIDINGER, RM
    VEBER, DF
    SIGAL, IS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) : 297 - 303
  • [8] DASH C, 1998, Patent No. 983560
  • [9] THE STRUCTURE AND FUNCTION OF THE ASPARTIC PROTEINASES
    DAVIES, DR
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOPHYSICAL CHEMISTRY, 1990, 19 : 189 - 215
  • [10] THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS
    DIXON, M
    [J]. BIOCHEMICAL JOURNAL, 1953, 55 (01) : 170 - 171